Latvija - latviešu - Zāļu valsts aģentūra

novartis poland sp. z o.o, poland - oktreotīds - Šķīdums injekcijām/infūzijām - 0,1 mg/ml

Latvija - latviešu - Zāļu valsts aģentūra

pfizer, s.a., spain - medroksiprogesterona acetāts - suspensija injekcijām - 150 mg/1 ml

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

scipharm sàrl - treprostinila nātrija hlorīds - hipertensija, plaušu slimība - antitrombotiskie līdzekļi - treatment of adult patients with who functional class (fc) iii or iv and:inoperable chronic thromboembolic pulmonary hypertension (cteph), orpersistent or recurrent cteph after surgical treatmentto improve exercise capacity.

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

bioveta, ,a.s., Čehija - tetanusa toksoīds - suspensija injekcijām - aitas; kazas; liellopi; suņi; zirgi

Latvija - latviešu - Zāļu valsts aģentūra

novartis pharma gmbh, germany - oktreotīds - Šķīdums injekcijām/infūzijām - 0,1 mg/ml

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - imunoloģiskie līdzekļi suidae - cūkas (nobarošanas) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - imūnsistēmas attiecībā uz cūku dzimtas zivīm - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

orion corporation - pregabalin - pretepilepsijas līdzekļi - kaķi - alleviation of acute anxiety and fear associated with transportation and veterinary visits.

Latvija - latviešu - Zāļu valsts aģentūra

novartis pharma gmbh, germany - oktreotīds - Šķīdums injekcijām/infūzijām - 0,1 mg/ml

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - maribavir - citomegalovīrusu infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). jāņem vērā oficiālās vadlīnijas par piemērotu izmantot pretvīrusu aģentu.